Stocks In Focus, June 10, 2026: FMCG, Pharma and Private Banks Stocks Outpace Broader Market Amid Global Macro Uncertainty

Mumbai, June 10: On Wednesday, defensive domestic consumption stocks along with private banks continued their recent outperformance vs the broader market as investors continued to rotate into safer corners amid worries over prolonged global macro uncertainty. The Nifty 50 was able to eke out only a slim gain by the close. 

FMCG Stocks Did Best 

The Nifty FMCG index outperformed the broader markets, rallying 1.78% to become the best performing sectoral index of the day. FMCG stocks benefited from rotation into domestic consumption themes as they look insulated from crude induced inflation & rupee depreciation. With global commodity prices cooling off and rural consumption showing early signs of pick-up ahead of the kharif season, FMCG stocks were rewarded with positive price moves and offered a stable earnings story. 

• Hindustan Unilever (HINDUNILVR: Rs 2,196.00) gained 2.96%, the strongest move among the FMCG majors, as investors priced in a demand recovery in home and personal care categories. 

• Nestlé India (NESTLEIND: Rs 1,443.50) rose 2.35%, supported by improving urban consumption trends and steady pricing power across its packaged food portfolio. 

• ITC (Rs 284.35) advanced 1.55%, with its diversified revenue streams spanning cigarettes, hotels, and agri-business lending the stock a defensive character that attracted incremental buying. 

• Tata Consumer Products (TATACONSUM, Rs 1,116.00) climbed 0.86%, continuing its gradual re-rating as investors focused on its distribution expansion and new product pipeline. 

Pharma & Healthcare: Earnings Visibility Drives Interest 

Nifty Pharma and Nifty Healthcare gained 0.64% and 0.68% respectively as hospital chains and pharma stocks drew investor interest. Investors remained focused on the sector’s domestic revenue, which is largely rupee agnostic, strong export order book and upcoming results season where companies are expected to report a steady recovery in margins. 

• Max Healthcare (Rs 1,013.55) rose 1.04%, benefiting from continued investor appetite for hospital stocks with capacity expansion underway and strong occupancy trends in the Delhi-NCR market. 

• Apollo Hospitals (Rs 8,603.50) gained 0.93%, supported by its integrated healthcare model and increasing traction in its digital health and pharmacy verticals. 

• Cipla (Rs 1,386.50) advanced 0.73%, with its diversified generics portfolio across the US, India, and emerging markets providing earnings stability that the market rewarded. 

• Sun Pharmaceutical Industries (Rs 1,789.20) added 0.57%, with the specialty pharma pivot continuing to underpin the bull case even as near-term US pricing headwinds linger. 

Private Banks: Rate Stability Fuels Re-Rating 

The Nifty Private Bank index climbed 1.13% to 26,849.75, supported by growing expectations that the Reserve Bank of India’s rate easing cycle will sustain credit demand growth while compressing provisions. Institutional buying was concentrated in quality large-cap names with proven asset quality metrics. 

• ICICI Bank surged 2.27% to Rs 1,304, leading private sector peers as investors continued to reward its improving return ratios and well-diversified retail and corporate loan book. 

• Axis Bank rose 2.12% to Rs 1,319.80, with sustained institutional accumulation reflecting confidence in its ongoing earnings normalisation following a period of elevated credit costs. 

• Kotak Mahindra Bank added 1.94% to Rs 389.10, recovering further as the market reassessed the growth trajectory under its new management team. 

• HDFC Bank gained 0.56% to Rs 742.45, a smaller move in percentage terms but significant in absolute buying volumes given its weight in both the index and institutional portfolios. 

 Sources: 

• https://www.nseindia.com/market-data/top-gainers-losers
• https://www.nseindia.com/market-data/live-equity-market?symbol=NIFTY%20PRIVATE%20BANK